Suraj Samtani, Head of Oncology at Las Condes Clinic and at Félix Bulnes Clinical Hospital and Director of the Chilean Society of Medical Oncology, shared a post on LinkedIn:
“Honoured to present real-world data from Latin American patients with non-small cell lung cancer (NSCLC) at the Foundation Medicine headquarters in Boston.
Precision medicine is no longer a future promise, it is already transforming how we understand and treat lung cancer across our region.
This experience highlights the growing importance of integrating clinico-genomic data to better understand tumor biology and treatment outcomes in diverse populations.
Data from Latin America remains underrepresented in global datasets. Generating and sharing this evidence is essential to identify actionable alterations, improve clinical decision-making, and expand access to precision oncology across our region.
Grateful for the kind invitation and the opportunity to share this work.
Precision oncology reaches its full potential when it reflects the diversity of patients worldwide.”
Suraj Samtani/LinkedIn
Other articles featuring Suraj Samtani on OncoDdaily.
